US00287Y1091
US00287Y1091
AbbVie Inc.
Loading chart...
Pure Price Volatility Risk (Market Swings)
The business itself is financially solid (Financial Health 70/100, minimal insolvency risk). The high overall score (6/7) is driven primarily by extreme stock price swings (±23.5% p.a.) and steep historical drawdowns.
Volatility Risk
Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.
Volatility Risk Score
6/7 High
6 / 7 SRI Price Fluctuation & Beta
Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.2x).
Beta (Market Relation)
0.23x
DefensiveVolatility (5Y p.a.)
23.5% p.a.
5-Year HorizonMax Drawdown (5Y)
-24.3%
5-Year HorizonSharpe Ratio
0.73
Return / RiskSpeculative / High Risk: Score Basis:
Multi-Horizon Risk & Performance Matrix
Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.
Timeframe | Volatility (p.a.) | Max Drawdown | Sharpe Ratio | Return (p.a.) |
|---|---|---|---|---|
| 1 Year | — | — | — | +17.8% |
| 3 Years | 24.9% | -21.5% | 0.79 | +22.2% |
| 5 Years | 23.5% | -24.3% | 0.73 | +19.6% |
| 10 Years | 26.1% | -48.9% | 0.51 | +15.7% |
Automated Risk & Health Notes (Red Flags)
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
🔴 High valuation risk: Avg P/E of 78.1 (Elevated multiple compression risk)